跳至主要内容
临床试验/NCT07305922
NCT07305922招募中不适用

Delayed Cerebral Infarction Beyond Endoluminal Spasmolysis and Induced Hypertension

Region Stockholm1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2025年12月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
1
主要终点
Mean Flow Velocity (MFV)

研究概览

简要总结

An observational study of patients with emerging or established severe cerebral vasospasm after subarachnoid haemorrhage, employing multimodal neuromonitoring.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults 18 years or older
  • Critical care after subarachnoid haemorrhage
  • Aneurysm secured by surgical clipping or endovascular procedure
  • Suspected, emerging or established severe cerebral vasospasm

排除标准

  • Anticipated survival less than five days, as determined by treating clinician
  • Transcranial Doppler signal too weak
  • Pregnancy

研究组 & 干预措施

Patients with emerging or established severe cerebral vasospasm after subarachnoid haemorrhage

干预措施: Induced hypertension with norepinephrine (Drug)

Patients with emerging or established severe cerebral vasospasm after subarachnoid haemorrhage

干预措施: Endoluminal Spasmolysis (Drug)

结局指标

主要结局

Mean Flow Velocity (MFV)

时间窗: Up to 12 hours post intervention

Increase or decrease of Mean Flow Velocity of the medial cerebral artery as determined by Transcranial Doppler.

次要结局

  • Duration of MFV change after Endoluminal Spasmolysis(Up to 12 hours)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Peter Rudberg

Senior Consultant, Research Group Leader

Karolinska Institutet

研究点 (1)

Loading locations...

相似试验